Biomarkers

ALZpath and Alamar Biosciences Expand Alzheimer’s Blood Test Partnership

by

ALZpath and Alamar Biosciences have expanded their strategic agreement to include clinical diagnostics for Alzheimer’s disease, granting Alamar commercial rights to utilize the proprietary pTau217 antibody in blood-based diagnostic tests intended for clinical use, according to the companies. The broadened collaboration follows an initial agreement from February 2024 that integrated the antibody into research use … Read more

Multi-Omic Biomarker Approach Validated for Ovarian Cancer Detection

by

A new peer-reviewed study published in the journal Diagnostics validates a multi-omic approach to detecting ovarian cancer, demonstrating that integrating lipidomic, metabolomic, and protein profiles offers higher clinical accuracy than single-modality tests. By analyzing 503 participants, researchers identified that ovarian cancer rewires multiple biological pathways simultaneously, providing the foundation for AOA Dx’s AKRIVIS GD diagnostic … Read more

New Blood Test Predicts Alzheimer’s Progression Using Circular RNAs

by

A set of 34 specific circular RNAs in the blood can predict the onset of Alzheimer’s disease symptoms, according to a study funded by the National Institutes of Health (NIH). Research indicates these markers can identify the transition to symptomatic Alzheimer’s two to four years before clinical signs appear, potentially improving patient selection for clinical … Read more

Classifying Breast Cancer Subtypes Using Raman Spectroscopy and Machine Learning

by

Raman spectroscopy (RS) can identify cancerous breast tissue with 97.84% sensitivity and 97.18% specificity, according to a study published in Nature Scientific Reports. By analyzing the molecular signatures of tissue samples, the technology distinguishes between healthy tissue and three distinct cancer subtypes—invasive ductal carcinoma, invasive lobular carcinoma, and ductal carcinoma in situ—offering a potential path … Read more

Fluorine-19 MRI Signal Phenotypes in Perfluorocarbon-Labeled Solid Tumors

by

The New Frontier of Oncology: Using $^{19}\text{F}$ MRI to Map the Cancer’s “Internal Support System” For decades, the fight against cancer has focused on a single target: the tumor itself. We’ve developed incredible tools to visualize the size, shape, and density of malignant masses. But there is a growing realization in the medical community that … Read more

HALP Score and In-Hospital Outcomes in Acute Kidney Injury

by

The New Frontier of Renal Care: How Biomarkers are Predicting Kidney Recovery In the high-stakes environment of an Intensive Care Unit (ICU), every minute counts. For patients battling Acute Kidney Injury (AKI), the margin between recovery and long-term renal failure—or even mortality—is razor-thin. Currently, AKI affects between 20% and 30% of all hospitalized patients, and … Read more

Early Alzheimer’s Detection: Brain Scans vs. Blood Tests

by

The Future of Alzheimer’s: Shifting from Late-Stage Reaction to Early Detection For decades, Alzheimer’s disease has been characterized as a diagnosis that arrives only after major symptoms manifest. However, the medical landscape is undergoing a paradigm shift. With new research published in The Lancet, the focus is moving toward detecting the disease years—or even decades—before … Read more

Simple Blood Test May Predict Alzheimer’s Years Before Brain Scans Show Signs

by

The Shift Toward Blood-Based Diagnostics in Neurology For years, diagnosing the earliest stages of Alzheimer’s disease required invasive procedures or expensive imaging. Lumbar punctures and amyloid PET scans were the gold standard, but they are often costly and difficult for many patients to access. We are now entering a latest era of neurology where a … Read more

How Fred Hutch scientists tackle world’s top infectious killer, TB

by

The Future of Tuberculosis Vaccination: A New Era of Precision and Protection For centuries, tuberculosis (TB) has remained a global health crisis. Now, a convergence of cutting-edge research, spearheaded by scientists at the Fred Hutchinson Cancer Center and collaborators worldwide, is poised to revolutionize TB prevention. The focus is shifting from broad-spectrum approaches to highly … Read more

New Tool Maps Hyperarousal Dimensions for Personalized Care

by

Beyond Fight or Flight: The Future of Personalized Mental Healthcare For decades, “hyperarousal” has been a catch-all term in mental health, describing a state of heightened alert. Now, a groundbreaking 2026 study published in eClinicalMedicine is changing that, identifying seven distinct dimensions of hyperarousal and introducing the Transdiagnostic Hyperarousal Dimensions Questionnaire (THDQ). This isn’t just … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]